Gapping down
In reaction to earnings/guidance:
- SMFR -20.4%, FUV -13.3%, MVST -13%, ZEV -11.9%, RBLX -6.6%, BHP -5.5%, GAN -4.4%, HUYA -4.2%, SAVE -4.1% (guides Q3 revs below consensus, cites significant irregular operations), TME -3.3%, HD -3.1%, NRXP -1.8%, GDS -1.6%, WMT -1%
Other news:
- HPK -8.5% (stock offering)
- UPST -4.9% (convertible notes offering)
- OPEN -4.3% (convertible notes offering)
- CLVS -1.9% (renews $125 mln "at-the-market" equity offering program)
- FL -1.4% (raises quarterly dividend by 50% to $0.30 per share)
- BGNE -0.9% (BeiGene and EUSA Pharma announce that the China National Medical Products Administration has granted QARZIBA conditional approval for the treatment of high-risk neuroblastoma)
- NPTN -0.5% (files for $150 mln mixed securities shelf offering)
Analyst comments:
- DXC -2.4% (downgraded to Underweight from Neutral at JP Morgan)
- COUP -1.6% (downgraded to Sector Perform from Outperform at RBC Capital Mkts)
- ALL -1.4% (downgraded to In-line from Outperform at Evercore ISI)
- ASAN -1% (downgraded to Sector Perform from Outperform at RBC Capital Mkts)
- ADP -0.8% (downgraded to Underweight from Neutral at JP Morgan)